Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Medicover - Margins hold, Achtung: reimbursement ahead

05 november 2026

<a id="bm-comp-566faa30-7c0a-426e-a893-1f5ff169f708" name="bm-comp-566faa30-7c0a-426e-a893-1f5ff169f708" class="BMCustomAnchor"></a><table><tr><td bm-component-id="566faa30-7c0a-426e-a893-1f5ff169f708" style="vertical-align: top; width:100.000000%;"><ul><li>Q3 sales and adj. EBITDA 2% below cons, EBIT 3% above</li><li>'26e/'27e/'28e adj. EBITDA -1.0%/-2.3%/-2.3% on leases</li><li>FVR unchanged at SEK 220-300 on minor estimate revisions</li></ul></td></tr></table><a id="bm-comp-d7b3a8f6-b312-49dd-abc3-41bc67649db2" name="bm-comp-d7b3a8f6-b312-49dd-abc3-41bc67649db2" class="BMCustomAnchor"></a><table><tr><td bm-component-id="d7b3a8f6-b312-49dd-abc3-41bc67649db2" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Sales light, margins hold</h3><p>Revenue (ex-India) grew by 6.0% (restated numbers) y-o-y, to EUR 571m (2% below Infront consensus), with org. growth of 8% and a 2pp FX headwind. The adj. EBITDA margin rose 20bps y-o-y to 17.8%. Healthcare Services grew 8.0% organically (price ~6.3pp) and lifted its EBITDA margin to 19.8% (19.1%), helped by sports/wellness and Polish ambulatory clinics. Polish and Romanian hospitals were softer, and members fell 4% on Romania. Diagnostic Services grew 8.5% organically (price ~4.3pp), driven by FFS up 10% and a richer test mix, with lab tests up 5.3%. The EBITDA margin slipped to 18.5% (18.7%), as Germany was held back, offsetting synergies in Romania and SEE. Softer hospital performance in Poland (lower public-revenue margins, salary inflation) and Romania may persist given the continued public reimbursement pressure. In Germany, the genetics reimbursement reform in force since October will lower the margin contribution going forward, with mitigating actions started but not quantified. Leverage fell to 2.7x (3.1x), partly on the India reclassification.</p><h3 class="bm-h3">Estimate changes</h3><p>We lower adj. EBITDA by 1.0%/2.3%/2.3% for '26e/'27e/'28e, mainly on lower lease cost assumptions. EPS is unchanged in '26e and falls 3.8%/10.0% in '27e/'28e, as we now model to fully reflect lease interest in net financials. Beyond repaying maturing loans (~EUR 450m), we make no assumption on the use of the India proceeds, so further deleveraging or M&amp;A would be EPS accretive. Our operational view is broadly unchanged. '26e includes India in H1.</p><h3 class="bm-h3">FVR unchanged at SEK 220-300</h3><p>We leave our FVR at SEK 220-300 given the limited scale of our revisions. The share is up ~22% LTM and currently trading at 10.6x/9.3x EV/EBITDA for '26e/'27e. We estimate an FCF yield of 6.7-7.6% and a dividend yield of 1.1-1.3% for '27e/'28e.</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-11-19 Tempest Security - Growth returns but margins lag Tempest Sec.. Analys
2026-11-19 Coor - Restarts the M&A engine Coor Analys
2026-11-18 Eltel - CMD: Growth follows the margin repair Eltel Analys
2026-11-16 Petrolia Noco - Q3 impacted by underlift Petrolia Noco Analys
2026-11-16 Proact - CMD takeaways: Clear path to 2030 targets Proact Analys
2026-11-16 Donkey Republic - Wins 1,700-bike Karlsruhe contract Donkey Repu.. Analys
2026-11-16 Ogunsen - Back to growth with a leaner base Ogunsen Analys
2026-11-15 Isofol Medical - Clinical momentum builds ahead o... Isofol Medical Analys
2026-11-13 Clavister - Scaling up with civilian business nex... Clavister Analys
2026-11-12 Generic - Seasonality in volumes with margins hol... Generic Analys
2026-11-12 Xplora Technologies - Strong beat, but shouldn't ... Xplora Tech.. Analys
2026-11-12 Clavister - Scalability on full display Clavister Analys
2026-11-12 Generic - Softer growth but stronger earnings Generic Analys
2026-11-11 Ferronordic - The new normal Ferronordic Analys
2026-11-11 Proact - New targets include adj. EPS doubling 20... Proact Analys
2026-11-11 Ferronordic - Positive trend continues Ferronordic Analys
2026-11-10 Proact - Ahead of CMD Proact Analys
2026-11-10 G5 Entertainment - Estimates raised on lower costs G5 Entertai.. Analys
2026-11-10 Coor - Momentum building in Norway Coor Analys
2026-11-09 Generic - A broader base to grow from Generic Analys